DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(23 sites)

United States

Arkansas Children's Hospital, Little Rock, Arkansas

UCSF Benioff Children's Hospital Oakland, Oakland, California

Rady Children's Hospital, San Diego, California

Stanford University, Stanford, California

Connecticut Children's Hospital, Hartford, Connecticut

Nicklaus Children's Hospital, Miami, Florida

Arnold Palmer Hospital for Children, Orlando, Florida

All Children's Hospital Johns Hopkins Medicine, St. Petersburg, Florida

St. Joseph's Children's Hospital, Tampa, Florida

Kapiolani Medical Center for Women and Children, Honolulu, Hawaii

Advocate Aurora Research Institute, Chicago, Illinois

Kentucky Children's Hospital, Lexington, Kentucky

Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville, Kentucky

Children's Mercy Hospitals and Clinics, Kansas City, Missouri

Cardinal Glennon Children's Medical Center, St Louis, Missouri

Hackensack University Medical Center, Hackensack, New Jersey

Levine Children's Hospital, Charlotte, North Carolina

Randall Children's Hospital, Portland, Oregon

Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey, Pennsylvania

Hasbro Children's Hospital, Providence, Rhode Island

Medical University of South Carolina, Charleston, South Carolina

Dell Children's Blood and Cancer Center, Austin, Texas

Canada

CHUQ, Québec, Quebec